Dr. Jeffrey Crawford
Overview
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere.
Dr. Crawford is highly rated in 23 conditions, according to our data. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).
His clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
20 Duke Medicine Cir, Durham, NC 27710
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Crawford has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Duke Cancer Center
Diane Reidy is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Reidy is highly rated in 18 conditions, according to our data. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.
UNC Hospitals Outpatient Center At Eastowne
Nigel Key is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Key is highly rated in 32 conditions, according to our data. His top areas of expertise are Hemophilia B, Hemophilia A, Blood Clots, and Sickle Cell Disease.
Duke University Health System Inc
David Ashley is a Hematologist and an Oncologist in Durham, North Carolina. Dr. Ashley is highly rated in 17 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.
Frequently Asked Questions about Dr. Jeffrey Crawford
How do I make an appointment with Dr. Jeffrey Crawford?
You can book an appointment with Dr. Jeffrey Crawford by calling their office at 919-681-6900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jeffrey Crawford a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey Crawford is classified as an Distinguished expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jeffrey Crawford specialize in?
While Dr. Jeffrey Crawford is a Hematology Oncology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Jeffrey Crawford participate in research or clinical trials?
Yes. Dr. Jeffrey Crawford has published 4 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Jeffrey Crawford's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jeffrey Crawford accept my insurance?
Dr. Jeffrey Crawford accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 919-681-6900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Crawford isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Crawford isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Crawford isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Crawford isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Crawford isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Crawford isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Adult Soft Tissue SarcomaDr. Crawford isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorDr. Crawford isAdvanced. Learn about Bone Tumor.
- Epithelioid SarcomaDr. Crawford isAdvanced. Learn about Epithelioid Sarcoma.
- FibrosarcomaDr. Crawford isAdvanced. Learn about Fibrosarcoma.
- LiposarcomaDr. Crawford isAdvanced. Learn about Liposarcoma.
- MesenchymomaDr. Crawford isAdvanced. Learn about Mesenchymoma.
- Experienced
- Lung NodulesDr. Crawford isExperienced. Learn about Lung Nodules.
- Metastatic Brain TumorDr. Crawford isExperienced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Crawford isExperienced. Learn about Neuroendocrine Tumor.
- PlasmacytomaDr. Crawford isExperienced. Learn about Plasmacytoma.
- Polymorphous Low Grade AdenocarcinomaDr. Crawford isExperienced. Learn about Polymorphous Low Grade Adenocarcinoma.
- Sickle Cell DiseaseDr. Crawford isExperienced. Learn about Sickle Cell Disease.